Wednesday, 3 January 2018

Dr Reddy’s Laboratories Fell Over 4.5 Percent Intraday As Investors Reacted

Dr Reddy’s Laboratories fell over 4.5 percent intraday as investors reacted to the receipt of establishment inspection report.

According to a report on CNBC-TV18, an EIR has been issued to the company’s Duvvada facility. The report further states that Duvvada facility status continues to be classified as official action initiated.

In pharmaceuticals parlance, OAI means a regulatory and / or admin sanctions by the drug regulator are initiated.

The channel also reported that 13 US FDA observation details were given to the unit in February-March 2017.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory

1 comment:

  1. OPTION CALL: BUY NMDC 150 CALL ABOVE 6.10 TARGETS 6.35/ 6.90/ 7.60 STOPLOSS 5.60